ClinicalTrials.gg
Drug

Ethyl LEUCYL-1-METHYL-D-TRYPTOPHANATE clinical trials

Its developmentBy Lumos Pharma, step by step2 company-led studies, furthest phase 1: when each phase was reached, its deals, target and what is ahead.
studies test it
3
open now
1
in phase 3
0
first study started
2017

How each study uses ethyl LEUCYL-1-METHYL-D-TRYPTOPHANATE is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ethyl LEUCYL-1-METHYL-D-TRYPTOPHANATE studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

NLG802 (indoximod Prodrug)
2

Development codes

NLG802
1

Studies by the year they started

3 studies that test it; most in 2017 (1)

Studies that test ethyl LEUCYL-1-METHYL-D-TRYPTOPHANATE, by start year
YearStudies
20171
20221
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3

Who runs them

Industry 2 · Other 1

NewLink Genetics Corporation (1) · Lumos Pharma (1) · Luke, Jason, MD (1)

Often tested with

Tested in the same studies.

Navoximod (1)

Studies

Open first, then newest update. How each study uses ethyl LEUCYL-1-METHYL-D-TRYPTOPHANATE is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Codes

What other systems call ethyl LEUCYL-1-METHYL-D-TRYPTOPHANATE · ClinicalTrials.gg INT017418

  • UNII (FDA) NVJ85QZ036ETHYL LEUCYL-1-METHYL-D-TRYPTOPHANATEOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.